Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02102867 · ClinicalTrials.gov registry record · NA
Developing Rectal USPE Measures
A NA study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02102867 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 18 participants.
The verdict
NCT02102867, a NA study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to: (a) adapt existing vaginal USPE items/instruments for evaluation of similar elements of rectal compartment use; (b) develop these scales using 3 distinct semi-solid formulations that represent a range of physicochemical and rheological properties of microbicides that are currently being designed for dual compartment use; and (c) develop novel USPE instruments to capture the experience of product use in the context of receptive anal intercourse (RAI) in both male and female cohorts.
Interventions
- OTHER Gel
- OTHER Cream
- OTHER Liquid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-04 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02102867
The ClinicalTrials.gov registry entry for NCT02102867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Gel is the first listed.
NCT02102867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02102867 about?
NCT02102867 is a clinical study titled "Developing Rectal USPE Measures". The purpose of this study is to: (a) adapt existing vaginal USPE items/instruments for evaluation of similar elements of rectal compartment use; (b) develop these scales using 3 distinct semi-solid formulations that represent a range of physicochemical and rheological properties of microbicides that...
What is the current status of trial NCT02102867?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-04. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT02102867?
The interventions under investigation include: Gel (OTHER), Cream (OTHER), Liquid (OTHER).
Who is sponsoring clinical trial NCT02102867?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.